GRCL Annual Shareholders Equity
$199.41 M
-$87.28 M-30.44%
31 December 2022
Summary:
As of February 4, 2025, GRCL annual stockholders equity is $199.41 million, with the most recent change of -$87.28 million (-30.44%) on December 31, 2022. During the last 3 years, it has risen by +$162.91 million (+446.38%).GRCL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRCL Quarterly Shareholders Equity
$222.18 M
+$65.48 M+41.78%
30 September 2023
Summary:
As of February 4, 2025, GRCL quarterly stockholders equity is $222.18 million, with the most recent change of +$65.48 million (+41.78%) on September 30, 2023. Over the past year, it has increased by +$65.48 million (+41.78%).GRCL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRCL Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -30.4% | +41.8% |
3 y3 years | +446.4% | +41.8% |
5 y5 years | +10000.0% | +41.8% |
GRCL Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -30.4% | -33.4% |
Gracell Biotechnologies Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2023 | - | $222.18 M(+41.8%) |
June 2023 | - | $156.71 M(-10.9%) |
Mar 2023 | - | $175.90 M(-11.8%) |
Dec 2022 | $199.41 M(-30.4%) | $199.41 M(-6.9%) |
Sept 2022 | - | $214.28 M(-11.0%) |
June 2022 | - | $240.80 M(-8.5%) |
Mar 2022 | - | $263.07 M(-8.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $286.69 M(+128.5%) | $286.69 M(-6.1%) |
Sept 2021 | - | $305.28 M(-4.8%) |
June 2021 | - | $320.63 M(-3.8%) |
Mar 2021 | - | $333.40 M(+165.7%) |
Dec 2020 | $125.46 M(+243.8%) | $125.46 M(+224.7%) |
Sept 2020 | - | $38.64 M(+5.9%) |
Dec 2019 | $36.50 M(>+9900.0%) | $36.50 M |
Dec 2018 | $346.40 K | - |
FAQ
- What is Gracell Biotechnologies annual stockholders equity?
- What is the all time high annual shareholders equity for Gracell Biotechnologies?
- What is Gracell Biotechnologies annual shareholders equity year-on-year change?
- What is Gracell Biotechnologies quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Gracell Biotechnologies?
- What is Gracell Biotechnologies quarterly shareholders equity year-on-year change?
What is Gracell Biotechnologies annual stockholders equity?
The current annual shareholders equity of GRCL is $199.41 M
What is the all time high annual shareholders equity for Gracell Biotechnologies?
Gracell Biotechnologies all-time high annual stockholders equity is $286.69 M
What is Gracell Biotechnologies annual shareholders equity year-on-year change?
Over the past year, GRCL annual stockholders equity has changed by -$87.28 M (-30.44%)
What is Gracell Biotechnologies quarterly stockholders equity?
The current quarterly shareholders equity of GRCL is $222.18 M
What is the all time high quarterly shareholders equity for Gracell Biotechnologies?
Gracell Biotechnologies all-time high quarterly stockholders equity is $333.40 M
What is Gracell Biotechnologies quarterly shareholders equity year-on-year change?
Over the past year, GRCL quarterly stockholders equity has changed by +$65.48 M (+41.78%)